Evidence map›Paper›PMID 21380797›Full record

ArticlePediatric nephrology (Berlin, Germany)2011

Plasma from a case of recurrent idiopathic FSGS perturbs non-muscle myosin IIA (MYH9 protein) in human podocytes.

Sima Babayeva, Michelle Miller, Yulia Zilber, Reyhan El Kares, Chantale Bernard, Martin Bitzan, Paul Goodyer, Elena Torban

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Pediatric nephrology (Berlin, Germany), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. The Role of Palladin in Podocytes.Journal of the American Society of Nephrology : JASN · 2018
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Non-muscle myosins and the podocyte.Clinical kidney journal · 2012
    Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Sima BabayevaDepartment of Medicine, McGill University, 3775 University Street, Montreal, QC, H3A2B4, Canada.
Michelle Miller
Yulia Zilber
Reyhan El Kares
Chantale Bernard
Martin Bitzan
Paul Goodyer
Elena Torban
McGill University · CA

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

The MYH9 gene encodes a non-muscle myosin IIA heavy chain (NMMHC-IIA) expressed in podocytes. Heterozygous MYH9 mutations cause a set of overlapping syndromes characterized by variable degrees of deafness, morphologic abnormalities of platelets and focal segmental glomerulosclerosis (FSGS) with progressive renal dysfunction. Similar glomerular lesions are seen in a variety of nephropathies, including an idiopathic form of FSGS in children which recurs in renal allografts, implying a circulating factor that affects glomerular podocyte biology. It is unknown whether NMMHC-IIA is perturbed in the idiopathic form of FSGS. We describe a pediatric patient with typical idiopathic FSGS, in whom proteinuria recurred within hours of deceased donor renal transplantation but who responded to plasmapheresis. We demonstrate in vitro that plasmapheresis effluent from our patient rapidly decreased cultured podocyte levels of the phosphorylated myosin light chain (MLC) that mediates NMMHC-IIA binding to actin and induced dispersion of NMMHC-IIA from its usual position along actin stress fibers. FSGS plasma also caused dispersion of slit diaphragm proteins (nephrin and podocin) and vinculin-positive focal adhesion complexes. Our observations suggest that the putative circulating factor in idiopathic FSGS disrupts normal NMMHC-IIA function in podocytes and might contribute to the pathogenesis of recurrent FSGS in other children.

Indexed as

AdolescentApoptosisCell LineCell SizeChildFemaleGlomerulosclerosis, Focal SegmentalHumansIntracellular Signaling Peptides and ProteinsKidney Failure, ChronicKidney TransplantationMembrane ProteinsMolecular Motor ProteinsMyosin Heavy ChainsMyosin Light ChainsPhosphorylationIntracellular Signaling Peptides and ProteinsMembrane ProteinsMolecular Motor ProteinsMYH9 protein, humanMyosin Heavy ChainsMyosin Light ChainsnephrinNPHS2 protein

Identifiers

PMID21380797
OpenAlexW2054135638

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.